Toggle light / dark theme

New COVID-19 Vaccine May Offer Broad Protection Against Existing and Future Coronavirus Strains at a Cost of $1

Posted in biotech/medical, health

A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and costs about $1 a dose has shown promising results in early animal testing.

Vaccines created by UVA Health’s Steven L. Zeichner, MD, PhD, and Virginia Tech’s Xiang-Jin Meng, MD, PhD, prevented pigs from being becoming ill with a pig model coronavirus, porcine epidemic diarrhea virus (PEDV). The vaccine was developed using an innovative approach that Zeichner says might one day open the door to a universal vaccine for coronaviruses, including coronaviruses that previously threatened pandemics or perhaps even coronaviruses that cause some cases of the common cold.

Their coronavirus vaccine offers several advantages that could overcome major obstacles to global vaccination efforts. It would be easy to store and transport, even in remote areas of the world, and could be produced in mass quantities using existing vaccine-manufacturing factories.

1 Comment so far

  1. What do the members of the biotech/medical board at lifeboat think of the graphene-oxide theory of covid?… that the graphene-oxide turns the human body into an transceiver? .… that humanity is being turned into an internet-of-bodies?

    I have not visited this site in years so will scout around looking for forums and active comments sections. Any help would be appreciated.

Leave a Reply